ONCOBIOLOGICS INC's ticker is ONS and the CUSIP is 68235M105. A total of 18 filers reported holding ONCOBIOLOGICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $670,000 | +15.9% | 683,531 | 0.0% | 0.03% | +40.9% |
| Q2 2018 | $578,000 | -4.9% | 683,531 | 0.0% | 0.02% | -24.1% |
| Q1 2018 | $608,000 | -31.6% | 683,531 | 0.0% | 0.03% | -50.0% |
| Q4 2017 | $889,000 | -5.0% | 683,531 | 0.0% | 0.06% | -20.5% |
| Q3 2017 | $936,000 | +36.8% | 683,531 | 0.0% | 0.07% | -15.1% |
| Q2 2017 | $684,000 | -62.7% | 683,531 | 0.0% | 0.09% | -63.2% |
| Q1 2017 | $1,832,000 | -10.9% | 683,531 | 0.0% | 0.23% | -43.8% |
| Q4 2016 | $2,057,000 | +7.4% | 683,531 | +51.6% | 0.42% | +23.8% |
| Q3 2016 | $1,916,000 | +20.7% | 450,872 | -3.4% | 0.34% | -4.8% |
| Q2 2016 | $1,587,000 | – | 466,667 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,216,498 | $3,752,000 | 0.22% |
| Avoro Capital Advisors LLC | 683,531 | $608,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 29,082 | $26,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 138,000 | $123,000 | 0.00% |
| Marshall Wace North America L.P. | 261,800 | $233,000 | 0.00% |
| Advisory Services Network, LLC | 2,000 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 10,000 | $9,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,165 | $9,000 | 0.00% |
| VANGUARD GROUP INC | 312,707 | $278,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 57,162 | $51,000 | 0.00% |